{"id":"bat2506-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Immune-related adverse events"},{"rate":null,"effect":"Infusion reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"BAT2506 functions as a bispecific monoclonal antibody designed to target and modulate multiple immune pathways simultaneously. By engaging dual immune checkpoints, it aims to overcome resistance mechanisms and amplify the body's natural anti-tumor immune response more effectively than single-target checkpoint inhibitors.","oneSentence":"BAT2506 is a bispecific antibody that simultaneously engages two immune checkpoints to enhance anti-tumor T cell responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:03:40.135Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced or metastatic solid tumors (Phase 3 development)"}]},"trialDetails":[{"nctId":"NCT04152759","phase":"PHASE1","title":"Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects","status":"COMPLETED","sponsor":"Bio-Thera Solutions","startDate":"2019-09-09","conditions":"Psoriatic Arthritis","enrollment":182},{"nctId":"NCT05332730","phase":"PHASE1","title":"A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®","status":"COMPLETED","sponsor":"Bio-Thera Solutions","startDate":"2022-08-01","conditions":"Psoriatic Arthritis","enrollment":375}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"BAT2506 injection","genericName":"BAT2506 injection","companyName":"Bio-Thera Solutions","companyId":"bio-thera-solutions","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BAT2506 injection is being studied in a clinical trial for the treatment of Psoriatic Arthritis. The study compares the pharmacokinetics and safety of BAT2506 injection to Simponi, a commercially available treatment for Psoriatic Arthritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}